Through Navican, patients at Intermountain can get tested on an internally developed NGS platform that gauges a range of actionable genes implicated in cancer.
Researchers have developed a positional mapping approach to be used in conjunction with exome sequencing to limit the search for causative variants.
The first apps will be for individuals at low risk for inherited forms of cancer and heart disease, and will require a doctor's permission.
The researchers hope that unbiased sequencing will improve their ability to identify infections caused by knee and hip replacements.
The service provides broad access to information that may be critical for physicians in providing precision cancer treatments.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.